Table 6.5Starting Hb level

Study referencePatient populationEvidence hierarchyHb level at baselineOutcome
27Continuous ambulatory peritoneal dialysis (CAPD)Level 3≤7.5 g/dl vs >7.5 g/dlTime to achieve Hb target was longer (p<0.001) in the lower Hb group at 6 months despite similar rate of Hb increase and epoetin dose in both groups.
71Children on haemodialysisLevel 3 vs ≥6.8 g/dl<6.8 g/dlA similar proportion of each group (81% vs 80%) reached the target Hb of 9.6–11.2 g/dl.
The median time to achieve target Hb was higher in the lower Hb group (median 13 weeks vs 9 weeks; p-value not reported by the authors).

From: 6, Assessment and optimisation of erythropoiesis

Cover of Anaemia Management in Chronic Kidney Disease
Anaemia Management in Chronic Kidney Disease: Rapid Update 2011 [Internet].
NICE Clinical Guidelines, No. 114.
National Clinical Guideline Centre (UK).
Copyright © 2011, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.